Covered recipient · General Payments record
JEROME G SMITH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$416.84
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $269.50 | 10 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $130.90 | 3 |
| Amarin Pharma Inc. | $61.55 | 3 |
| Vanda Pharmaceuticals Inc. | $44.28 | 2 |
| Lilly USA, LLC | $32.77 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $18.38 | 02/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815335033 | CMS |
| Amarin Pharma Inc. | $20.87 | 03/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815419515 | CMS |
| Amarin Pharma Inc. | $22.30 | 06/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815156385 | CMS |
| Lilly USA, LLC | $17.94 | 02/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818567025 | CMS |
| Lilly USA, LLC | $14.83 | 03/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818566939 | CMS |
| Novo Nordisk Inc | $12.22 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811069401 | CMS |
| Novo Nordisk Inc | $98.72 | 06/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811748181 | CMS |
| Novo Nordisk Inc | $19.96 | 08/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811535815 | CMS |
| Vanda Pharmaceuticals Inc. | $25.87 | 03/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838913443 | CMS |
| Vanda Pharmaceuticals Inc. | $18.41 | 07/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838913445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021
- Source files
- Dataset page · Bulk file · PY2018 , PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.